Insider Shareholders with Direct Ownership of Qualigen Therapeutics, Inc. (QLGN)
This section provides a comprehensive overview of the insiders with direct ownership of Qualigen Therapeutics, Inc. (QLGN). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Qualigen Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Michael S. Poirier
Chairman and CEO |
30,000 | 0 | 199,202 $33,864 | 1 |
Jun 22, 2022
Added 13.09%
|
|
Amy S. Broidrick
President/CSO |
34,500 | 0 | 34,500 $5,865 | 2 |
Jun 14, 2022
Added 46.51%
|
|
Kurt H Kruger
Director |
18,000 | 0 | 18,000 $3,060 | 4 |
Aug 19, 2021
Added 18.18%
|
|
Christopher L. Lotz
Vice President of Finance, CFO |
2,700 | 0 | 12,541 $2,131 | 1 |
Apr 16, 2021
Added 17.72%
|